Human Metabolome Technologies, Inc.
Tokyo Stock ExchangeTotal Valuation
Human Metabolome Technologies, Inc. carries a market capitalization of 3.39B, placing it among publicly traded companies globally. Its enterprise value stands at 2.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.39B |
| Enterprise Value | 2.17B |
Share Statistics
Human Metabolome Technologies, Inc. currently has 5.92M shares outstanding.
| Shares Outstanding | 5.92M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Human Metabolome Technologies, Inc. trades at a trailing price-to-earnings ratio of 15.35. The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 1.96.
| PE Ratio | 15.35 |
| PS Ratio | 2.77 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Human Metabolome Technologies, Inc. trades at an EV/EBITDA multiple of 9.86 and an EV/FCF ratio of 1,115.77. The EV/Sales ratio of 1.61 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.86 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.61 |
| EV / EBITDA | 9.86 |
| EV / EBIT | 9.86 |
| EV / FCF | 1,115.77 |
Financial Position
Human Metabolome Technologies, Inc. maintains a current ratio of 3.31, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.62, indicating elevated leverage, while an interest coverage ratio of 105.09 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.31 |
| Quick Ratio | 2.83 |
| Debt / Equity | 11.62 |
| Debt / EBITDA | 1.03 |
| Interest Coverage | 105.09 |
Financial Efficiency
Human Metabolome Technologies, Inc. posts a return on equity of 13.43 and a return on invested capital of 9.73.
| Return on Equity (ROE) | 13.43 |
| Return on Assets (ROA) | 9.94 |
| Return on Invested Capital (ROIC) | 9.73 |
| Return on Capital Employed (ROCE) | 12.03 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 15.07 |
Taxes
Over the trailing twelve months, Human Metabolome Technologies, Inc. has paid 18.65M in income taxes, reflecting an effective tax rate of 7.12.
| Income Tax | 18.65M |
| Effective Tax Rate | 7.12 |
Stock Price Statistics
Human Metabolome Technologies, Inc.'s stock has declined approximately -18.88298% over the past 52 weeks. The 50-day moving average sits at 648.06, while the 200-day moving average is 682.21.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.88298% |
| 50-Day Moving Average | 648.06 |
| 200-Day Moving Average | 682.21 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Human Metabolome Technologies, Inc. generated 1.35B in revenue and converted that into 243.25M in net income, yielding earnings per share of 41.18. EBITDA reached 220.17M, while operating income came in at 220.17M.
| Revenue | 1.35B |
| Gross Profit | 869.33M |
| Operating Income | 220.17M |
| Pretax Income | 261.90M |
| Net Income | 243.25M |
| EBITDA | 220.17M |
| EBIT | 220.17M |
| Earnings Per Share (EPS) | 41.18 |
Balance Sheet
Human Metabolome Technologies, Inc. holds 1.79B in cash and equivalents against 226.30M in total debt, resulting in a net debt position of -1.59B. Total book value stands at 1.91B, with working capital of 1.46B providing operational flexibility.
| Cash & Cash Equivalents | 1.79B |
| Total Debt | 226.30M |
| Net Debt | -1.59B |
| Equity (Book Value) | 1.91B |
| Book Value Per Share | 322.50 |
| Working Capital | 1.46B |
Margins
Human Metabolome Technologies, Inc. operates with a gross margin of 64.60, reflecting its pricing power and cost economics. The operating margin of 16.36 and net profit margin of 18.08 provide insight into operational efficiency.
| Gross Margin | 64.60 |
| Operating Margin | 16.36 |
| Pretax Margin | 19.46 |
| Profit Margin | 18.08 |
| EBITDA Margin | 16.36 |
Scores
Human Metabolome Technologies, Inc. posts an Altman Z-Score of 5.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.12 |